Human immunodeficiency virus-associated nephropathy (HIVAN) affects up to 1
0% of HIV-positive black adults and children and is the leading cause of re
nal disease in infected individuals. The disease is characterized by prolif
eration of renal epithelial cells, both glomerular and tubular. Diseased ki
dneys are enlarged, and glomerular visceral epithelial cells (podocytes) ex
press proliferation markers. In a transgenic murine model of HIVAN expressi
ng a deletion construct of HIV-1, the identical pathologic features are obs
erved. It was demonstrated that HIV-1 mRNA is expressed in renal epithelium
of the transgenic mouse and in patients with HIVAN, suggesting a direct ro
le for HIV-1 in disease pathogenesis in both humans and the murine model. F
or investigating the mechanisms responsible for proliferative changes in po
docytes, the HIV-1 transgenic mouse was bred onto the immortomouse backgrou
nd, and conditionally immortalized transgenic and nontransgenic podocyte ce
ll lines were established. Transgenic podocytes demonstrated increased spon
taneous proliferation, compared with nontransgenic podocytes at confluence,
and they were found to have a greater percentage of cells in the prolifera
tive phase of the cell cycle. It is striking that transgenic podocytes were
not contact inhibited and formed aggregates in soft agar. Aggregates also
formed when nontransgenic podocytes were infected with the identical HIV-1
construct used to generate the transgenic model. This demonstrates that the
loss of contact inhibition is due to a direct effect of HIV-1. Therefore,
proliferation induced by HIV-1 gene expression is likely to play a key role
in the pathogenesis of HIVAN.